TOLREMO therapeutics

• locale

  Germany

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.tolremo.com

TOLREMO therapeutics focuses on developing compounds to block mechanisms of non-genetic cancer drug resistance. They have developed lead candidate TT125-802, an orally available small molecule inhibitor targeting gene transcription involved in cancer cell resistance.